One of the strategies of antitumor therapy is the inhibition of protein kinases by low-molecular-weight ATP mimetic compounds which block oncogene-induced cell signaling pathways, affect the proteins that regulate gene functions, induce the apoptosis of cancer cells, etc. [41]. This evidence concerns the gene WEE1 and cancer.